Episode 25: Stem cell therapy: Is it ready for Prime Time FxMed?

Episode 25: Stem cell therapy: Is it ready for Prime Time FxMed? With Dr. Tami Meraglia

As you probably know, stem cell therapy outside of the research setting is the Wild West. It’s offered everywhere, here and outside of the US (there’s a whole “stem cell tourism trade”). Radical claims are made routinely without much evidence or oversight. Pricing for therapy and protocols used vary widely, although anyone (even those participating in research trials) can expect to spend thousands of dollars.

Episode 18: Dr Daniel Kalish, CEO and Founder of the Kalish Institute

Episode 18: Launching a Soul-Satisfying and Financially Successful FxMed Practice with Dr. Daniel Kalish

Dr. Alschuler is a world-renowned expert in integrative oncology. Lise is well-versed in the current literature and has done a remarkable job in translating findings into actionable steps (listen for her approach to the five key bodily pathways in oncogenesis and how to address them). A teacher to her core, Lise a mentor to many of us, myself included. This is a jam-packed discussion on cancer prevention and management, from the soul-searching demands of a cancer diagnosis to highly practical treatment approaches.

Episode 17: Cancer Prevention and Management: A Conversation with Dr. Lise Alschuler

Episode 17: Cancer Prevention and Management: A Conversation with Dr. Lise Alschuler

Dr. Alschuler is a world-renowned expert in integrative oncology. Lise is well-versed in the current literature and has done a remarkable job in translating findings into actionable steps (listen for her approach to the five key bodily pathways in oncogenesis and how to address them). A teacher to her core, Lise a mentor to many of us, myself included. This is a jam-packed discussion on cancer prevention and management, from the soul-searching demands of a cancer diagnosis to highly practical treatment approaches.

Episode 16: Cancer as a Mitochondrial Metabolic Disease & The Calorie-Restricted Ketogenic Diet

Episode 16: Cancer as a Mitochondrial Metabolic Disease & The Calorie-Restricted Ketogenic Diet with Dr. Thomas Seyfried

Dr. Seyfried has dedicated his career to changing the way we think about- and therefore treat- cancer. Going back to Otto Warburg and others, couple with newer research Tom and his colleagues are actively conducting, it’s clear that the origin of cancer is in a fundamental disruption of mitochondrial oxidative phosphorylation.